These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24605778)

  • 1. Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.
    Stearman RS; Cornelius AR; Lu X; Conklin DS; Del Rosario MJ; Lowe AM; Elos MT; Fettig LM; Wong RE; Hara N; Cogan JD; Phillips JA; Taylor MR; Graham BB; Tuder RM; Loyd JE; Geraci MW
    Am J Respir Crit Care Med; 2014 May; 189(9):1110-20. PubMed ID: 24605778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomic complexity underlying pulmonary arterial hypertension: from mendel to networks.
    Rajkumar R; Ahmad F
    Am J Respir Crit Care Med; 2014 May; 189(10):1152-4. PubMed ID: 24832737
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.
    Zhou L; Chen Z; Vanderslice P; So SP; Ruan KH; Willerson JT; Dixon RA
    Circulation; 2013 Aug; 128(9):982-94. PubMed ID: 23841984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    Gubrij IB; Pangle AK; Pang L; Johnson LG
    PLoS One; 2016; 11(1):e0147827. PubMed ID: 26815432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin synthase promoter regulation and familial pulmonary arterial hypertension.
    Nana-Sinkam P; Oyer RJ; Stearman RS; Sotto-Santiago S; Moore MD; Bull TM; Grady MC; Choudhery Q; Nemenoff RA; Lane K; Loyd JE; Geraci MW
    Chest; 2005 Dec; 128(6 Suppl):612S. PubMed ID: 16373865
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics and genomics of pulmonary arterial hypertension.
    Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension.
    Amano S; Tatsumi K; Tanabe N; Kasahara Y; Kurosu K; Takiguchi Y; Kasuya Y; Kimura S; Kuriyama T
    Respirology; 2004 Jun; 9(2):184-9. PubMed ID: 15182267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of pulmonary arterial hypertension.
    Elliott CG
    Clin Chest Med; 2013 Dec; 34(4):651-63. PubMed ID: 24267296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Song J; Hinderhofer K; Kaufmann LT; Benjamin N; Fischer C; Grünig E; Eichstaedt CA
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
    Pfarr N; Szamalek-Hoegel J; Fischer C; Hinderhofer K; Nagel C; Ehlken N; Tiede H; Olschewski H; Reichenberger F; Ghofrani AH; Seeger W; Grünig E
    Respir Res; 2011 Jul; 12(1):99. PubMed ID: 21801371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic basis of pulmonary arterial hypertension.
    Ma L; Chung WK
    Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
    Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
    PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
    Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.
    Girerd B; Coulet F; Jaïs X; Eyries M; Van Der Bruggen C; De Man F; Houweling A; Dorfmüller P; Savale L; Sitbon O; Vonk-Noordegraaf A; Soubrier F; Simonneau G; Humbert M; Montani D
    Chest; 2015 May; 147(5):1385-1394. PubMed ID: 25429696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.